The EMBO Journal

The EMBO Journal
Title	The EMBO Journal
Discipline	Molecular biology
Abbreviation	EMBO J.
Editor	European Molecular Biology Organization
Publisher	EMBO Press
Country	Europe
History	1982–present
Frequency	Biweekly
Openaccess	Hybrid
Impact	11.3
Impact-year	2023
Issn	0261-4189

The EMBO Journal The EMBO Journal is a peer-reviewed scientific journal focusing on molecular biology, cell biology, and related life-science research. Founded in the early 1980s, it is published by EMBO Press and has become a central venue for primary research and reviews that influence work in genetics, biochemistry, and developmental biology. The journal interfaces with major research institutions and scholarly societies across Europe, North America, and Asia, attracting manuscripts from Nobel laureates, laboratory heads, and translational research consortia.

History

The journal was established with ties to European Molecular Biology Organization, launched amid institutional developments involving European Molecular Biology Laboratory, EMBL members, and funders such as the Wellcome Trust and Human Frontier Science Program. Early editorial leadership drew on scientists from Max Planck Society, Pasteur Institute, University of Cambridge, and Karolinska Institutet, intersecting networks that included Cold Spring Harbor Laboratory, Rockefeller University, and Institute Pasteur. During the 1980s the journal paralleled advances reported by groups at Harvard University, Massachusetts Institute of Technology, University of California, San Francisco, and Stanford University Medical Center. Through the 1990s and 2000s its editorial board incorporated investigators from European Research Council-funded teams, crosslinking with laboratories at University of Oxford, University of Edinburgh, University of Munich, and ETH Zurich. Collaborations and editorial policies were informed by standards used by Nature Publishing Group, Cell Press, and Proceedings of the National Academy of Sciences. The 2010s saw EMBO Press initiatives coordinate with Public Library of Science, bioRxiv, and funders including National Institutes of Health and Wellcome Trust on preprint and open-access practices. Recent history includes responses to reproducibility debates highlighted by commentators from Max Planck Institute for Biophysical Chemistry, Francis Crick Institute, and European Commission advisory panels.

Scope and content

The journal publishes original research articles, reviews, and commentaries spanning topics investigated at institutions such as Johns Hopkins University, Yale University, University of Toronto, Karolinska Institutet, and Imperial College London. Subject matter commonly includes gene regulation studies from groups at Cold Spring Harbor Laboratory and Salk Institute for Biological Studies, structural biology reports tied to work at European Synchrotron Radiation Facility and Diamond Light Source, and cell-signalling investigations linked to labs at University of Cambridge and Max Planck Institute for Molecular Cell Biology and Genetics. Contributions often discuss mechanisms elucidated by teams from Howard Hughes Medical Institute, Riken, CNRS, and University of California, Berkeley and techniques developed at Addgene, Wellcome Sanger Institute, and Broad Institute. The journal features advances in genome editing credited to laboratories related to Broad Institute, CRISPR-Cas9 pioneers, and groups at University of California, San Diego. Reviews synthesize perspectives from awardees of Lasker Award, Nobel Prize, and recipients of fellowships from EMBO and Gordon and Betty Moore Foundation.

Editorial structure and publication model

Editorial governance combines professional editors and academic editors drawn from organizations like European Molecular Biology Organization, Royal Society, Academy of Sciences Leopoldina, and National Academy of Sciences. The peer-review process follows conventions similar to those practiced by Nature, Science (journal), and Cell (journal), with oversight from editorial offices staffed in collaboration with groups at EMBL-EBI. Manuscripts undergo assessment by reviewers from universities such as UCLA, McGill University, University of Tokyo, and Seoul National University. Publication models include traditional subscription access and hybrid open access aligned with funder mandates from Wellcome Trust, Bill & Melinda Gates Foundation, and European Research Council. Policies on data availability and reproducibility reference repositories like GenBank, Protein Data Bank, ArrayExpress, and preprint servers such as bioRxiv.

Abstracting and indexing

The journal is indexed in major databases maintained by organizations including Clarivate Analytics (formerly Thomson Reuters), PubMed Central, MEDLINE, and Scopus (Elsevier). Abstracting services such as EMBASE and indexing platforms used by libraries at Library of Congress, British Library, and Deutsche Nationalbibliothek ensure discoverability alongside aggregators like Google Scholar and CrossRef. Citation tracking appears in analytics managed by Web of Science, Scopus (Elsevier), and altmetrics providers collaborating with entities like Altmetric and Plum Analytics.

Impact and reception

The journal's impact factor and reputation have been discussed in contexts involving citation analyses by Journal Citation Reports, commentary in editorial pages of Nature, and policy discussions at European Commission science directorates. Influential articles in the journal have been cited in reviews and meta-analyses by groups at Cochrane Collaboration and policy briefs from World Health Organization. Critical reception has come from scholars linked to Stanford University, Massachusetts Institute of Technology, University College London, and University of California, San Francisco debating standards for reproducibility and peer review, paralleling broader conversations involving PLOS, eLife, and Frontiers. The journal is routinely used as a benchmark by faculty committees at Princeton University, Columbia University, University of Chicago, and Duke University for promotion and tenure evaluations.

Notable articles and contributions

Notable papers published in the journal include discoveries in chromatin biology by researchers associated with Cold Spring Harbor Laboratory, breakthroughs in apoptosis pathways from laboratories at Massachusetts General Hospital, and seminal reports on transcriptional regulation from teams at University of Oxford and Yale University. Landmark methodological contributions have come from groups at EMBL, Max Planck Institute, Salk Institute for Biological Studies, and Broad Institute, while influential reviews synthesized by scholars from Karolinska Institutet and University of Cambridge have shaped subsequent work referenced by Nobel Prize laureates. The journal has hosted early reports connected to technologies developed at Addgene, CRISPR Therapeutics, and institutions such as Riken and RIKEN Center for Developmental Biology, and has been cited in clinical translational research at Mayo Clinic, Cleveland Clinic, and Mount Sinai Health System.

Category:Biology journals Category:Academic journals established in 1982 Category:EMBO publications